Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly

por Sydney B Long, Michael J Blaha, Roger S Blumenthal, et al
Publicado 2010

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty

por Olusola A Orimoloye, Albert D Osei, SM Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J Blaha
Publicado 2019

ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE

por Ellen Boakye, Iftekhar Uddin, Olufunmilayo H. Obisesan, Albert D. Osei, Omar Dzaye, Garima Sharma, John W. McEvoy, Roger S. Blumenthal, Michael J. Blaha
Publicado 2021

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015

por Victor Okunrintemi, Javier Valero-Elizondo, Neil J. Stone, Ron Blankstein, Michael J. Blaha, Martha Gulati, Salim S. Virani, William A. Zoghbi, Erin D. Michos, Khurram Nasir
Publicado 2021

Higher cardiorespiratory fitness predicts long-term survival in patients with heart failure and preserved ejection fraction: the Henry Ford Exercise Testing (FIT) Project

por Olusola A. Orimoloye, Swetha Kambhampati, Albert J. Hicks III, Mahmoud Al Rifai, Michael G. Silverman, Seamus Whelton, Waqas Qureshi, Jonathan K. Ehrman, Steven J. Keteyian, Clinton A. Brawner, Zeina Dardari, Mouaz H. Al-Mallah, Michael J. Blaha
Publicado 2019